Brisdelle (paroxetine mesylate)

DRUG4 trials

Sponsors

Noven Therapeutics

Conditions

Hot FlashesPostmenopausal Symptoms

Phase 1

Pharmacokinetic Evaluation of Brisdelle™ (Formerly Known as Mesafem) Following Single & Repeat Oral Administration in Healthy Postmenopausal Women

CompletedNCT01829919

Noven TherapeuticsPostmenopausal Symptoms

Start: 2011-07-31End: 2011-08-31Updated: 2015-10-15

Phase 2

Eight-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms Associated With Menopause

CompletedNCT00786188

Noven TherapeuticsHot Flashes

Start: 2008-11-30End: 2009-06-30Updated: 2015-10-15

Phase 3

24-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms

CompletedNCT01101841

Noven TherapeuticsHot Flashes

Start: 2010-03-31End: 2011-11-30Updated: 2015-10-15

Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS)

CompletedNCT01361308

Noven TherapeuticsPostmenopausal Symptoms

Start: 2011-05-31End: 2012-02-29Updated: 2015-10-15